334 related articles for article (PubMed ID: 20003285)
1. Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study.
Gustafsson J; Gunnarsson I; Börjesson O; Pettersson S; Möller S; Fei GZ; Elvin K; Simard JF; Hansson LO; Lundberg IE; Larsson A; Svenungsson E
Arthritis Res Ther; 2009; 11(6):R186. PubMed ID: 20003285
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study.
Gustafsson JT; Simard JF; Gunnarsson I; Elvin K; Lundberg IE; Hansson LO; Larsson A; Svenungsson E
Arthritis Res Ther; 2012; 14(2):R46. PubMed ID: 22390680
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with cardiovascular events in systemic lupus erythematosus in a monocentric cohort with up to 40 years of follow-up.
Farina N; Webster J; Luo W; Garelick D; Pinto SM; Isenberg D; Rahman A
Semin Arthritis Rheum; 2023 Aug; 61():152226. PubMed ID: 37201214
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
[TBL] [Abstract][Full Text] [Related]
5. Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
Gustafsson JT; Herlitz Lindberg M; Gunnarsson I; Pettersson S; Elvin K; Öhrvik J; Larsson A; Jensen-Urstad K; Svenungsson E
PLoS One; 2017; 12(4):e0174572. PubMed ID: 28414714
[TBL] [Abstract][Full Text] [Related]
6. Maternal-placental syndrome and future risk of accelerated cardiovascular events in Parous Swedish women with systemic lupus erythematosus - a population-based retrospective cohort study with time-to-event analysis.
Soh MC; Dib F; Nelson-Piercy C; Westgren M; McCowan L; Pasupathy D
Rheumatology (Oxford); 2016 Jul; 55(7):1235-42. PubMed ID: 27016663
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study.
Bengtsson C; Ohman ML; Nived O; Rantapää Dahlqvist S
Lupus; 2012 Apr; 21(4):452-9. PubMed ID: 22065097
[TBL] [Abstract][Full Text] [Related]
8. Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus.
Svenungsson E; Cederholm A; Jensen-Urstad K; Fei GZ; de Faire U; Frostegård J
Scand J Rheumatol; 2008; 37(5):352-9. PubMed ID: 18666029
[TBL] [Abstract][Full Text] [Related]
9. Raised plasma levels of asymmetric dimethylarginine are associated with cardiovascular events, disease activity, and organ damage in patients with systemic lupus erythematosus.
Bultink IE; Teerlink T; Heijst JA; Dijkmans BA; Voskuyl AE
Ann Rheum Dis; 2005 Sep; 64(9):1362-5. PubMed ID: 16100343
[TBL] [Abstract][Full Text] [Related]
10. Predisposing factors to nonfatal cardiovascular events in women with systemic lupus erythematosus. An observational, cross-sectional, multicenter study in Spain from the risk/systemic lupus erythematosus thematic network.
Fernández-Garcés M; Haro G; Micó ML
Medicine (Baltimore); 2019 Oct; 98(43):e17489. PubMed ID: 31651851
[TBL] [Abstract][Full Text] [Related]
11. Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus.
Magder LS; Petri M
Am J Epidemiol; 2012 Oct; 176(8):708-19. PubMed ID: 23024137
[TBL] [Abstract][Full Text] [Related]
12. Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients.
Somers EC; Zhao W; Lewis EE; Wang L; Wing JJ; Sundaram B; Kazerooni EA; McCune WJ; Kaplan MJ
PLoS One; 2012; 7(5):e37000. PubMed ID: 22606325
[TBL] [Abstract][Full Text] [Related]
13. Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus.
Fasano S; Pierro L; Pantano I; Iudici M; Valentini G
J Rheumatol; 2017 Jul; 44(7):1032-1038. PubMed ID: 28507183
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.
Unlu O; Erkan D; Barbhaiya M; Andrade D; Nascimento I; Rosa R; Banzato A; Pengo V; Ugarte A; Gerosa M; Ji L; Efthymiou M; Branch DW; de Jesus GR; Tincani A; Belmont HM; Fortin PR; Petri M; Rodriguez E; Pons-Estel GJ; Knight JS; Atsumi T; Willis R; Zuily S; Tektonidou MG;
Arthritis Care Res (Hoboken); 2019 Jan; 71(1):134-141. PubMed ID: 29669399
[TBL] [Abstract][Full Text] [Related]
15. Novel cardiovascular risk factors and cardiac event predictors in female inactive systemic lupus erythematosus patients.
Karadag O; Calguneri M; Atalar E; Yavuz B; Akdogan A; Kalyoncu U; Bilgen SA; Ozer N; Ertenli AI; Ovunc K; Kiraz S
Clin Rheumatol; 2007 May; 26(5):695-9. PubMed ID: 16909327
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome is not only a risk factor for cardiovascular diseases in systemic lupus erythematosus but is also associated with cumulative organ damage: a cross-sectional analysis of 311 patients.
Demir S; Artim-Esen B; Şahinkaya Y; Pehlivan Ö; Alpay-Kanıtez N; Omma A; Erer B; Kamalı S; Gül A; Aral O; Öcal L; İnanç M
Lupus; 2016 Feb; 25(2):177-84. PubMed ID: 26354963
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
Chock YP; Moulinet T; Dufrost V; Erkan D; Wahl D; Zuily S
Autoimmun Rev; 2019 Nov; 18(11):102395. PubMed ID: 31520800
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine, antiphospholipid antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
Martínez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Rueda M; Aguirre C
Lupus; 2004; 13(12):927-33. PubMed ID: 15645748
[TBL] [Abstract][Full Text] [Related]
19. Clinical associations of proinflammatory cytokines, oxidative biomarkers and vitamin D levels in systemic lupus erythematosus.
Willis R; Smikle M; DeCeulaer K; Romay-Penabad Z; Papalardo E; Jajoria P; Harper B; Murthy V; Petri M; Gonzalez EB
Lupus; 2017 Dec; 26(14):1517-1527. PubMed ID: 28467291
[TBL] [Abstract][Full Text] [Related]
20. [Cardiac abnormalities in patients with systemic lupus erythematosus: the role of antiphospholipid antibodies].
Monti M; Borgognoni F; Pastacci L; Vincentelli GM
G Ital Cardiol (Rome); 2016 Dec; 17(12):1001-1007. PubMed ID: 28151504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
